α-synuclein in the pathophysiology of Alzheimer's disease.

Twohig D, Nielsen HM. · 2019

Read α-synuclein in the pathophysiology of Alzheimer's disease. by Twohig D, Nielsen HM. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6558879.txt.

Description

Twohig and Nielsen review the case that α-synuclein, the Parkinson's protein, also helps drive Alzheimer's disease, writing in Molecular Neurodegeneration. Alzheimer's is defined by amyloid plaques and tau tangles. Yet Lewy-type deposits built from α-synuclein appear in over half of autopsied Alzheimer's brains, and in nearly all cases of the inherited form.

The authors assemble the evidence strand by strand. Spinal fluid α-synuclein rises early, tracks with amyloid buildup and predicts faster decline. Lab work links the protein to tau's harmful phosphorylation, to amyloid's actions, and to the APOEε4 risk gene shared by both diseases. Sections on the protein's structure and normal job at synapses ground the argument: α-synuclein may be an active player in Alzheimer's, not a bystander.

Catalog record

CREATORTwohig D, Nielsen HM.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE102 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6558879

Browse the full library · About the Tower of Babel